(Q50867766)

24 March 2018

title

The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin. (English)

1 reference

24 March 2018

1 reference

Gorski JC

1

1 reference

24 March 2018

Jones DR

2

1 reference

24 March 2018

Haehner-Daniels BD

3

1 reference

24 March 2018

Hamman MA

4

1 reference

24 March 2018

O'Mara EM Jr

5

1 reference

24 March 2018

Hall SD

6

1 reference

24 March 2018

language of work or name

English

0 references

publication date

1 August 1998

1 reference

24 March 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

24 March 2018

volume

64

1 reference

24 March 2018

page(s)

133-143

1 reference

24 March 2018

issue

2

1 reference

24 March 2018

Erythromycin enhances the absorption of cyclosporin

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

Dose of midazolam should be reduced during diltiazem and verapamil treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

Extra-hepatic metabolism of midazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

A potentially hazardous interaction between erythromycin and midazolam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

Rifampin drastically reduces plasma concentrations and effects of oral midazolam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

The effect of ingestion time interval on the interaction between itraconazole and triazolam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

Troleandomycin-triazolam interaction in healthy volunteers: pharmacokinetic and psychometric evaluation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

Influence of age on the pharmacokinetics of alfentanil. Gender dependence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

Effect of age and gender on tirilazad pharmacokinetics in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

Hepatic cytochrome P-4503A (CYP3A) activity in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

Effect of age and gender on the activity of human hepatic CYP3A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

Aging and alfentanil disposition in healthy volunteers and surgical patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

Age-dependent cyclosporine: pharmacokinetics in marrow transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

Clarithromycin pharmacokinetics in healthy young and elderly volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

The effect of age upon liver volume and apparent liver blood flow in healthy man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

The pharmacokinetics of midazolam in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

The human hepatic cytochromes P450 involved in drug metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

Pharmacokinetic drug interactions with rifampicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

First-pass metabolism of midazolam by the human intestine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

Polymorphic metabolism of mephenytoin in man: pharmacokinetic interaction with a co-regulated substrate, mephobarbital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

In vitro forecasting of drugs which may interfere with the biotransformation of midazolam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

Particular ability of cytochromes P450 3A to form inhibitory P450-iron-metabolite complexes upon metabolic oxidation of aminodrugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990146-1

10.1016/S0009-9236(98)90146-1

7 January 2021

Identifiers

DOI

1 reference

24 March 2018

release_7vrbxvupxfd73j5tr5pse33dra

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7vrbxvupxfd73j5tr5pse33dra

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

9728893

1 reference

24 March 2018